Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

por Farfan-Portet, María-Isabel, Gerkens, Sophie, Lepage-Nefkens, Isabelle, Vinck, Irmgard, Hulstaert, Frank
Publicado 2013

Early modelling of the effects and healthcare costs of the Dutch citizen-rescuer system for out-of-hospital cardiac arrests

por Ahmed, Anam, Mewes, Janne C., Lepage-Nefkens, Isabelle, Tan, Hanno L., Vrijhoef, Hubertus J. M.
Publicado 2023